R&G Pharma Studies, a Beijing, China-based CRO, has broadened its adoption of Medidata's Clinical Cloud, becoming the first Chinese customer to use Medidata CTMS. R&G provides a full range of clinical trial services including regulatory affairs, clinical monitoring, data manageOriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.